Alterity Therapeutics (ATHE) Other Non-Current Liabilities (2012 - 2025)

Alterity Therapeutics has reported Other Non-Current Liabilities for 11 years, with the latest figure at -$1.7 million in Q2 2025.

• On a quarterly basis, Other Non-Current Liabilities fell 3866.26% year-over-year to -$1.7 million in Q2 2025; TTM through Jun 2025 was -$1.7 million, a 3866.26% decrease from a year earlier, with the FY2025 full-year figure at -$1.7 million, down 3866.26% from the prior year.
• Other Non-Current Liabilities was -$1.7 million for Q2 2025 at Alterity Therapeutics, down from $28197.3 in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $49804.0 in Q4 2023, with the low at -$1.7 million in Q2 2025.
• Average Other Non-Current Liabilities over 5 years is -$207676.8, with a median of -$44096.6 recorded in 2024.
• The sharpest annual moves came in 2023 and 2025: Other Non-Current Liabilities soared 158.42% in 2023, then slumped 3866.26% in 2025.
• Over 5 years, Other Non-Current Liabilities stood at $19470.6 in 2021, then slipped by 1.02% to $19272.4 in 2022, then surged by 158.42% to $49804.0 in 2023, then plunged by 43.38% to $28197.3 in 2024, then slumped by 6302.68% to -$1.7 million in 2025.
• The last three Other Non-Current Liabilities figures came in at -$1.7 million (Q2 2025), $28197.3 (Q4 2024), and -$44096.6 (Q2 2024), per Business Quant data.